MREO vs V · $48.7M cap vs P/E 33, rev $40.00B
Mereo BioPharma Group PLC ADR (MREO) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan M. McInerney.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
MREO currently screens at market cap $48.7M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the MREO and V stock pages for the full models.
Not investment advice.